RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
JCR Pharmaceuticals Co Stock

JCR Pharmaceuticals Co Net Income 2024

JCR Pharmaceuticals Co Net Income

5.51 B JPY

Ticker

4552.T

ISIN

JP3701000006

WKN

889627

In 2024, JCR Pharmaceuticals Co's profit amounted to 5.51 B JPY, a 46% increase from the 3.77 B JPY profit recorded in the previous year.

The JCR Pharmaceuticals Co Net Income history

YEARNET INCOME (undefined JPY)
2027e4.78
2026e4.64
2025e5.03
20245.51
20233.77
202214.51
20216.89
20202.68
20193.72
20183.07
20171.86
20161.79
20151.68
20141.3
20130.73
20120.63
20110.93
20101.3
20090.54
20080.4
2007-1.75
2006-0.04
2005-1.28

JCR Pharmaceuticals Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into JCR Pharmaceuticals Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by JCR Pharmaceuticals Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects JCR Pharmaceuticals Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of JCR Pharmaceuticals Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into JCR Pharmaceuticals Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing JCR Pharmaceuticals Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on JCR Pharmaceuticals Co’s growth potential.

JCR Pharmaceuticals Co Revenue, EBIT and net profit per share

DateJCR Pharmaceuticals Co RevenueJCR Pharmaceuticals Co EBITJCR Pharmaceuticals Co Net Income
2027e41.95 B undefined0 undefined4.78 B undefined
2026e41.66 B undefined0 undefined4.64 B undefined
2025e41.9 B undefined0 undefined5.03 B undefined
202442.87 B undefined7.53 B undefined5.51 B undefined
202334.34 B undefined4.98 B undefined3.77 B undefined
202251.08 B undefined19.93 B undefined14.51 B undefined
202130.09 B undefined8.27 B undefined6.89 B undefined
202024.78 B undefined3.24 B undefined2.68 B undefined
201923.16 B undefined4.97 B undefined3.72 B undefined
201820.59 B undefined3.78 B undefined3.07 B undefined
201718.09 B undefined2.36 B undefined1.86 B undefined
201617.44 B undefined2.15 B undefined1.79 B undefined
201516.86 B undefined2.01 B undefined1.68 B undefined
201415.71 B undefined1.55 B undefined1.3 B undefined
201314.1 B undefined1.15 B undefined731 M undefined
201212.85 B undefined1.09 B undefined634 M undefined
201114.46 B undefined1.41 B undefined926 M undefined
201014.39 B undefined2.01 B undefined1.3 B undefined
200912.08 B undefined546 M undefined540 M undefined
200811.87 B undefined212 M undefined400 M undefined
20078.55 B undefined-406 M undefined-1.75 B undefined
20067.65 B undefined-296 M undefined-42 M undefined
20058.1 B undefined459 M undefined-1.28 B undefined

JCR Pharmaceuticals Co stock margins

The JCR Pharmaceuticals Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of JCR Pharmaceuticals Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for JCR Pharmaceuticals Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the JCR Pharmaceuticals Co's sales revenue. A higher gross margin percentage indicates that the JCR Pharmaceuticals Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the JCR Pharmaceuticals Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the JCR Pharmaceuticals Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the JCR Pharmaceuticals Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the JCR Pharmaceuticals Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the JCR Pharmaceuticals Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

JCR Pharmaceuticals Co Margin History

JCR Pharmaceuticals Co Gross marginJCR Pharmaceuticals Co Profit marginJCR Pharmaceuticals Co EBIT marginJCR Pharmaceuticals Co Profit margin
2027e72.9 %0 %11.39 %
2026e72.9 %0 %11.14 %
2025e72.9 %0 %12 %
202472.9 %17.57 %12.85 %
202374.13 %14.49 %10.98 %
202279.52 %39.02 %28.4 %
202174.03 %27.49 %22.91 %
202068.12 %13.09 %10.81 %
201970.27 %21.45 %16.04 %
201868.5 %18.37 %14.91 %
201766.24 %13.06 %10.3 %
201661.03 %12.35 %10.26 %
201559.89 %11.95 %9.98 %
201453.26 %9.84 %8.25 %
201364.28 %8.16 %5.18 %
201267.2 %8.49 %4.94 %
201163.84 %9.73 %6.4 %
201071.21 %13.96 %9.06 %
200970.57 %4.52 %4.47 %
200867.19 %1.79 %3.37 %
200764.18 %-4.75 %-20.49 %
200658.92 %-3.87 %-0.55 %
200554.89 %5.67 %-15.85 %

JCR Pharmaceuticals Co Aktienanalyse

What does JCR Pharmaceuticals Co do?

JCR Pharmaceuticals Co. Ltd is a Japanese company founded in 1975. It is a global provider of biopharmaceutical products and services and is based in Ashiya, Japan. The company specializes in researching and developing therapies for rare genetic diseases, including the production of recombinant proteins and antibodies. It has three main business areas: biopharmaceuticals, diagnostics, and research services. JCR Pharmaceuticals works closely with universities, research institutions, and other companies to advance biotechnology research. It follows an ethical business model focused on integrity, transparency, openness, and fairness. The company has expanded into Europe and invested in a new research and development facility to enhance its presence and improve access to novel therapies for patients. Overall, JCR Pharmaceuticals has a strong position in the biotechnology and rare diseases field and has the potential to positively impact the lives of millions of people worldwide. JCR Pharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding JCR Pharmaceuticals Co's Profit Margins

The profit margins of JCR Pharmaceuticals Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of JCR Pharmaceuticals Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating JCR Pharmaceuticals Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

JCR Pharmaceuticals Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When JCR Pharmaceuticals Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about JCR Pharmaceuticals Co stock

How much profit has JCR Pharmaceuticals Co made this year?

JCR Pharmaceuticals Co has made 5.51 B JPY this year.

How has the profit developed compared to last year?

The profit has increased by 46% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does JCR Pharmaceuticals Co publish its earnings?

JCR Pharmaceuticals Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of JCR Pharmaceuticals Co?

The profits of JCR Pharmaceuticals Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of JCR Pharmaceuticals Co?

You can learn more about the earnings of JCR Pharmaceuticals Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does JCR Pharmaceuticals Co pay?

Over the past 12 months, JCR Pharmaceuticals Co paid a dividend of 20 JPY . This corresponds to a dividend yield of about 2.95 %. For the coming 12 months, JCR Pharmaceuticals Co is expected to pay a dividend of 24.33 JPY.

What is the dividend yield of JCR Pharmaceuticals Co?

The current dividend yield of JCR Pharmaceuticals Co is 2.95 %.

When does JCR Pharmaceuticals Co pay dividends?

JCR Pharmaceuticals Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of JCR Pharmaceuticals Co?

JCR Pharmaceuticals Co paid dividends every year for the past 23 years.

What is the dividend of JCR Pharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 24.33 JPY are expected. This corresponds to a dividend yield of 3.58 %.

In which sector is JCR Pharmaceuticals Co located?

JCR Pharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von JCR Pharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of JCR Pharmaceuticals Co from 12/1/2024 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did JCR Pharmaceuticals Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of JCR Pharmaceuticals Co in the year 2023?

In the year 2023, JCR Pharmaceuticals Co distributed 20 JPY as dividends.

In which currency does JCR Pharmaceuticals Co pay out the dividend?

The dividends of JCR Pharmaceuticals Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von JCR Pharmaceuticals Co

Our stock analysis for JCR Pharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of JCR Pharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.